lipids recovered from the brain following the injection of (3-'4C) serine into 11-day-old rabbits myelination is complete is fully in line with the findings in the earlier experiments with cholesterol. It seems that these two lipid constituents of myelin undergo little if any turnover in normal animals. In a structure so intrinsically elaborate as the laminated myelin sheath it is difficult to suppose that some of its molecules could ordinarily be abstracted and replaced at frequent intervals without some dislocation of its architecture. It seems justifiable, therefore, to infer that in health the myelin sheath in its entirety is a stable tissue element with little or no evidence of metabolic turnover.
One of the main purposes of a symposium is lost if its participants confine themselves wholly to established findings and pay no regard to such conjectures as the work may suggest. If the myelin sheaths are such stable tissue elements, then their dissolution in multiple sclerosis would seem to suggest that some attack has been made upon them from their immediate surroundings. If this speculation is justifiable, two considerations at once attract attention: (1) What could be the nature of any such potentially myelinolytic agent, whether a foreign or a natural product? (2) What sort of material immediately surrounds the sheaths which could provide access for such an agent? The former will be discussed by Professor Thompson. I shall confine myself to a discussion of the second point.
Of the many questions that are awaiting answer for progress in neuropathology few are more urgent than whether or not the central nervous system possesses, as do all other organs, a tissue fluid in which all its elements are immersed. On this fundamental matter, which has regrettably failed to attract as much interest from physiologists as its nature demands, opinions derived from two invaluable technical methods are diametrically at variance. The electron microscopists have almost unanimously rejected the idea of such a fluid, though recently one or two have made some very limited, almost grudging, concessions. Pharmiacologists, studying the distribution of such substances as thiocyanate and sodium, have supposed the existence of a tissue space that occupies from a quarter to a third of the brain. If the latter view is correct it would be possible for any myelinolytic agent, irrespective of whether it was produced locally or escaped from nearby blood vessels, to approach the sheaths through the fluid that presumably surrounds them. On the other hand, if the picture presented by electron microscopy is the correct one, it seems that the injurious agent must be formed in the cytoplasm of the enveloping glial cells that are believed to be in contact with them.
This doubtwhether there is a tissue fluid in the brainexemplifies the drawbacks that are inescapably associated with our present fragmentary attacks on the complex problems of diseases of the central nervous system. Progress in neuropathogenesis will inevitably be retarded unless answers to some of these questions can be provided by investigators in other conventional fields of medical science. This is unlikely to happen unless the proponents of one method compare their findings and conclusions with those obtained by other procedures.
Myelinolytic Mechansms by Professor R H S Thompson DM (London)
In considering the pathogenesis of multiple sclerosis one is at once brought up against the problem of the biochemical mechanism involved in the development in the central nervous system of localized areas of demyelination. One view, put forward many years ago (Marburg 1906) , is that the demyelinated plaques may be the outcome of the local action of some substance causing a direct breakdown or lysis of some component of the myelin sheath. This 'myelinolytic' theory immediately poses, however, the further question as to the chemical nature of such a hypothetical lytic substance.
Since the chief chemical components of the myelin sheath are protein and lipid, abnormal breakdown of these components by a hydrolytic enzyme, a proteinase or a lipase, is one possibility. A further possibility would be that cell lysis and solubilization of myelin might be initiated by some surface-active, lytic substance, non-enzymic in nature, such as lysolecithin or some other lysophosphatide, or even by a longchain fatty acid such as the 11, 12-octadecenoic acid which was shown by Laser (1949) to be present in considerable amounts in brain and to be actively htmolytic.
We have, over the past few years, been studying the brain in the hope of identifying substances that might, under pathological conditions, exert lytic effects, and so might possibly play a part in initiating the process of demyelination. Our belief in the value of this approach has recently been greatly strengthened by the results recently obtained by Professor Payling Wright and his colleagues in their study of the turnover of various myelin components. They have shown that the injection of 14C-labelled cholesterol into developing chicks, at a time when myelination is proceeding rapidly, is followed by the persistence of this labelled cholesterol in the brain for long periods of time, in contrast to its relatively rapid disappearance from other tissues, such as the liver, kidney or heart ). Furthermore, radioactive serine, a precursor of sphingosine, has been shown to persist with only little change in the sphingomyelin and cerebroside fractions of the brain lipids for up to nearly 200 days ) while 32P-labelled phosphate, when once incorporated into brain lipids, shows also only a very slow fall .
From this and other work it has been concluded that myelin, when once laid down, persists with little change over long periods of time. That is to say, once myelination of a tract is complete, the components of those myelin sheaths appear to be stable and not to be taking part in any active 'turnover' process involving their continued breakdown and resynthesis. If this is so, and there is considerable evidence in support of it, then interference with myelin synthesis in already myelinated tracts becomes unlikely, and it is more likely that demyelination arises as a result of some locally released or locally acting myelinolytic agent bringing about degradation of the metabolically stable proteolipid layers of the myelin sheath.
Numerous attempts have been made in the past to demonstrate the presence of such substances in the body fluids of patients with multiple sclerosis (Weil et al. 1935 , Weil & Heilbrunn 1941 , Birkmayer & Neumayer 1957 , Wolfgram & Rose 1958 . The methods used for the detection of these neurolytic substances have not, however, been conclusive, since they have involved in most cases long periods of incubation of nervous tissue with the fluids under investigation, up to 72 hours in some cases, followed by histological staining for myelin. Despite this, it has on more than one occasion been claimed that both the C.S.F. and the serum from patients with multiple sclerosis can cause in vitro demyelination of nervous tissue, whereas exposure of such tissue to C.S.F. or serum from normal subjects has no or only minimal effect.
Turning to specific chemical substances known to be cytolytic, at least towards red blood cells, it has been shown experimentally both by Morrison & Zamecnik (1950) in America and by Birkmayer & Neumayer (1957) in Vienna that both lysolecithin and phospholipase A, the enzyme that forms lysolecithin from lecithin, can in vitro cause demyelinating changes in central nervous tissue. And it has been suggested by these groups of workers and also by Debuch (1957) that the formation or release of lysolecithin or other lysophosphatide may play a part in the pathogenesis of the plaques of multiple sclerosis. We have therefore recently centred our attention upon a study of lysolecithin and the enzymes concerned in its formation and destruction, in order to examine in more detail the action that such substances may have on nervous tissue, and secondly to determine the extent to which such substances may be present in the normal brain.
The ability of lysolecithin to solubilize myelin and to bring about lysis of the various types of cell found in the brain has been demonstrated (Webster 1957).
Further evidence that small amounts of lysolecithin or phospholipase can rapidly damage cell membranes sufficiently to allow the outward diffusion and escape of intracellular protein molecules was obtained by measuring the outflow from brain slices into the fluid in which they were suspended of an intracellular enzyme, glutamicoxaloacetic transaminase (McArdle et al. 1960) . In these experiments the released glutamic-oxaloacetic transaminase was used as an index of cell membrane damage in the same way that the release of heemoglobin from within red blood cells is used as an index of hemolysis. It will be seen (Table 1) that both lysolecithin and phospho- lipase A cause a very extensive outflow of this intracellular enzyme even within ten minutes of their addition to the system. In addition to this release of transaminase we have shown thsat both true and pseudo-cholinesterase also escape from brain slices (Table 2) under the influence of lysolecithin (Marples et al. 1959) .
From these results it seems clear that if phospholipase A or free lysolecithin were to gain access to nervous tissue, both solubilization of myelin and lysis of both nerve and glial cells might be expected. Moreover, we have shown that the cell lysis causes the release of a number of hydrolytic enzymes in a fully active state. In addition to the enzymes mentioned above alkaline phosphatase and a proteinase are also fully active in brain homogenates after 'clearing' with lysolecithin. These enzymes, after their release from their normal intracellular locations, might possibly play a part in prolonging and extending the local destructive action brought about originally by the added lysolecithin.
It seemed desirable therefore next to determine whether lysolecithin is a normal component of brain tissue. If this were so, then its excessive formation, or altered metabolism, might be expected, in view of its known cytolytic and solubilizing properties, to give rise to damage.
The presence of lysolecithin in lipid extracts ofa number of mammalian tissues other than brain has recently been reported. It is not yet clear in all these cases whether it is formed during the chemical manipulations from the breakdown of other lipids, such as the lecithins or choline-containing plasmalogens, or whether it is a true component of the tissue in vivo. If indeed the latter is true one would expect that it might exist in some 'bound' form, in a complex perhaps with some other component of cell membranes.
Its presence in lipid extracts of brain had not, however, been described, although in 1932 Pighini in Italy had obtained a fraction from human brain which, both from its solubility properties and its biological actions, appeared to resemble a lysophosphatide. Dr Niemiro, Dr Webster and I therefore set about to reinvestigate Pighini's work, using more modern chromatographic methods for the separation oflysolecithin.
By means of chromatography on alumina columns, followed by chromatography on silicic acid-impregnated papers, we have regularly been able to demonstrate the presence of a substance which we have now identified as lysolecithin in total lipid extracts of both rat and human brain . If this substance, after separation from the other more rapidly moving choline-containing phosphatides, is eluted from the paper, it is found to be hemolytic, and also to give the analytical data expected of lysolecithin, the ratios of P: choline: fatty acid in the molecule being close to 1: 1 : 1 (Table 3 ). Confirmatory evidence of a preliminary nature that this substance is lysolecithin has also been obtained by infra-red spectroscopy, carried out by Dr W L G Gent in the Biochemistry Department at Guy's Hospital Medical School. From the data given in Table 3 it will be seen that we have identified lyso- Table 3 Analytical data on the lysolecithin extracted from brain 1-01 lecithin in lipid extracts obtained from rat brain (extracted within three minutes of killing the animals), in a post-operative specimen of human frontal grey matter (kindly provided by Mr Wylie McKissock), in post-mortem human grey matter, and also in plaque tissue dissected from the brain from a case of multiple sclerosis. Although we are still working on this problem, we feel that we have sufficient evidence to indicate that this lysolecithin is probably a physiological component of our lipid extracts of brain and is not formed solely by breakdown of other lipids in our extracts. We have not yet put these initial observations on a firm quantitative basis, but from the results which we have so far obtained there seems to be about 0-5-2 mg lysolecithin/g fresh brain tissue, i.e. it would correspond to about 10-20 % of the lecithin content of brain.
In view of these findings it is of interest to know whether brain tissue also contains the enzyme phospholipase A, which can form lysolecithin from lecithin, and the phospholipase B, which breaks down lysolecithin to glycerylphosphorylcholine and free fatty acid.
Phospholipase B is certainly present in human brain (Marples & Thompson 1960) , although the activity is only a very small fraction of that present in certain other tissues such as lung, intestine, liver and spleen. In brain the enzyme appears to be present almost exclusively in the grey matter.
Phospholipase A activity in the nervous system, as far as we have been able to discover, has not as yet been described. Dr Magee and I are now studying the distribution of this enzyme using an assay system suitable for application to mammalian tissues (Magee & Thompson 1960) . This work is still in its very early stages, but preliminary experiments appear to indicate that rat brain contains a low level of phospholipase A activity. It must be remembered that breakdown of lecithin by phospholipase A activity is not the only possible pathway of lysolecithin formation; direct biosynthesis, possibly as a precursor of lecithin, is also possible.
We feel that we now have evidence indicating the possible presence in brain of a potentially lytic, solubilizing substance, lysolecithin. Whether release of this substance, or a disorder of the enzyme systems responsible for its formation or removal, is in any way connected with the demyelination process is at present unknown, but we are hoping, after putting our observations in the normal brain on a more quantitative basis, to extend this approach to a study of the nervous system in allergic encephalomyelitis, and if only material can be obtained, to examine the nervous system from cases of multiple sclerosis. 
DISCUSSION
Dr H Bauer (Hamburg, Germany) said that he and his colleagues using Wieme's agar technique of electrophoresis had tried to find out which protein fractions from brain homogenates occurred with sufficient regularity to serve as a basis for preparative work, and also if a quantitative evaluation of the brain protein pherogram was of diagnostic value. In 150 brain samples, they had found 11 protein fractions occurring with sufficient regularity to warrant consideration, 2 of them corresponding to the pre-albumin, 1 to albumin, 3 to a, 2 to fi, 1 to T and 2 to the y globulin range.
There were no conspicuous differences in various areas of the brain.
In a comparison of the quantitative distribution of the fractions in a variety of conditions, the only conspicuous deviation had consisted of an increase of y globulin in instances of panencephalitis.
Brain tissue pherograms were subject to errors because of the varying amounts of hemoglobin, which migrated with the , globulin, in the homogenates. In desanguinated rat brain tissue the / globulin fraction amounted to only 10%, as compared to over 20% in brain homogenates from unbled rats. A similar inference had been made previously by Robertson using paper electrophoresis (unpublished data). In bloodfree brain tissue of the rats, the fractions showing the mobility of a globulins constituted almost 80 % of the total extractable brain proteins.
He believed that immunochemical studies with antisera prepared from these fractions should show whether there was a certain protein fraction in brain tissue associated with immunological phenomena leading to demyelination. If so, this might provide an antigen for a useful diagnostic test in D.S. In addition enzyme studies in total protein extracts as well as in electrophoretically separated fractions might prove interesting in the lysolecithin studies of Professor Thompson.
Dr Charles Poser (Kansas City) asked if Dr Finean agreed with Dr de Robertis' suggestion that, in the central nervous system, the myelin sheath was derived from concentrically layered bodies formed initially in the cytoplasm of the glial cells and deposited on the surface of the axon. He asked Professor Payling Wright if he had demonstrated the ability of the embryonic brain to synthesize cholesterol from precursors such as acetate or acetoacetate. The completion of gross myelination seemed to correspond roughly to the establishment of the blood brain barrier, and thus the embryonic brain would have to exercise this synthetic ability before the blood brain barrier became completely impermeable.
Professor Lumsden asked Dr Finean if it was possible to predict what the permeability properties and the permeability mechanism were likely to be in the myelin sheath. Was each lamella as permeable to agents acting from outside as a uni-lamellar cell membrane? How was this multi-lamellar system likely to be penetrated by enzymes, antibodies and such agentsdirectly from without inwards, or along the intraperiod line?
He asked also if the word 'durability' of myelin (in the sense of chemical myelin) reflected simply the 'durability' or the viability of the satellite or sheath cell. Dr Finean, in reply to Dr Poser, thought the intermediate stages of myelination had not yet been clearly demonstrated in the central nervous system, but they had been well established for peripheral nerve, and evidence of the initial invagination of the Schwann cell membrane and subsequent spiralling of double membrane layers around the axon could be clearly seen in the fully myelinated fibre. Such evidence could also be seen in the myelinated fibres of the central nervous system. The inner myelin layer divided at the inner mesaxon and enveloped the axon with a single membrane layer, which clearly indicated that the axon was initially enclosed in an invagination in a cell membrane. It was also clear that the myelin sheath was a continuous wrapping, and not a succession of independent myelin layers.
As for the suggestion made by de Robertis that the myelin sheath was derived from vacuoles or layered bodies formed independently in the cytoplasm of the cell, he could only suggest that if such bodies did contribute to the myelin sheath then they must do so by being incorporated in the mesaxon which was spiralling around the axon. If, however, de Robertis was suggesting the direct deposition of layered bodies on the axon surface to form myelin layers, he did not see how he was going to account for the existence of the inner mesaxon and the spiralling of the myelin layers.
In reply to Professor Lumsden, the penetration of the myelin layers from outside depended on the direction of penetration. Penetration along a radial axis would mean penetration through a hundred or more close-packed membrane layers which must provide a very formidable barrier. Penetration along the myelin layers starting from the outer mesaxon and following a spiral route eventually emerging at the inner mesaxon was another possibility. Here it might be imagined that the water component of the myelin would present a continuous aqueous channel following a spiral course through to the axon. However, it had been demonstrated that the water component (30 to 500%) of the myelin was largely organized in relation to the lipid and protein ionic groups and little was known about transport along an organized water system. It was impossible to predict what resistance would be met along such a pathway.
Their studies of myelin had shown that relatively small modification of the ionic medium led reversibly to inhomogeneities in the myelin layers. In terms of a single membrane this would be equivalent to producing numerous patches of membrane of reduced thick-ness. Such patches would appear to be of modified composition and might have modified permeabi'ity properties. This possibility of inhomogeneities being readily produced in the cell membrane by fluctuations in ionic conditions in its immediate neighbourhood was worth pursuing further.
Professor G Payling Wright, in answer to Dr Poser, said that with regard to the blood-brain barrier in the chickens and rabbits, it could hardly be doubted that the radioactive cholesterol passed into the brain unchanged. The fact that the radioactive carbon atom was at the same site in the molecule in the cholesterol recovered from their brains, as it was in that injected twelve months before, excluded the possibility that the lipid had undergone any breakdown and re-synthesis in the central nervous system. In the serine experiments, there was no evidence to show whether the cholesterol ultimately recovered from the brain was synthesized there or in some other organ, such as the liver, and then carried to the brain. It was known that cholesterol could be synthesized in the brain from acetate, and this might have happened in these experiments. The conclusion as to the persistence of the myelin lipids, however, was unaffected by whether the radioactive cholesterol entered the brain as such or whether it was formed in the organ.
He agreed with Professor Lumsden that the durability of the myelin sheaths was linked to the persistence of the satellite cells-it could hardly be supposed that the sheaths would remain unaffected by their loss. But in addition to the possibility that the breakdown of these cells might initiate primary demyelinationas was now believed to happen in experimental allergic encephalomyelitisthere was a further conceivable destructive mechanism that needed consideration. As Dr Finean had pointed out, there seemed to be places along the course of a fibre where its myelin was not wholly protected by any covering glial cell. If such lacuna proved to be a structural feature of normal fibres in the central nervous system such bare areas would provide sites at which the sheath might be exposed directly to any myelinolytic agent.
Professor R H S Thompson, in reply to Dr Bauer, said that Dr W L G Gent had carried out some observations on the electrophoretic behaviour of proteins in lysolecithin-cleared brain homogenates (Gent, 1959, Biochem. J. 73, 6P) .
In reply to a question from Dr Poser, Professor Thompson and his associates had examined a few specimens from patients with disseminated sclerosis, but had found the C.S.F. levels of glutamic-oxaloacetic transaminase within normal limits, a finding in agreement with those of a number of other workers. It had to be remembered, however, that the area of tissue undergoing active change at any one time in a patient with disseminated sclerosis, when considered in relation to the total volume of the C.S.F., was likely to be very small compared with the conditions existing in their in vitro studies in which they had added lysolecithin to approximately 100 mg of brain tissue in a total volume of 3 ml.
